Evroxim powder 1.5 g. vial №10


Manufacturer: Italy



Treatment of infections caused by microorganisms sensitive to cefuroxime, or treatment of infections before determining the pathogen of the infectious disease. Infectious diseases of the respiratory tract: acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative chest infections; infectious diseases of the throat and nose: sinusitis, tonsillitis, pharyngitis; infectious diseases of the urinary tract: acute and chronic pyelonephritis, cystitis, asymptomatic bacteriuria; infectious diseases of soft tissues: cellulite, erysipeloid, wound infection; infectious diseases of bones and joints: osteomyelitis, septic arthritis; infections in obstetrics and gynecology: infectious and inflammatory diseases of the pelvic organs; gonorrhea, especially in cases where penicillin is contraindicated; other infectious diseases, including septicaemia and meningitis. Prevention of infectious complications after operations on the chest and abdomen, pelvic organs, vascular, cardiovascular and orthopedic operations. In most cases, monotherapy with Euroxime is effective, but if necessary, the drug can be used in combination with aminoglycoside antibiotics or metronidazole (orally, in suppositories or by injection). In the case of existing or anticipated mixed aerobic and anaerobic infections (e.g. peritonitis, aspiration pneumonia, lung abscess, pelvic and brain) and the high incidence of such infections (e.g., surgery of the colon and gynaecological surgery) it is acceptable to use Proximo in combination with metronidazole. In the treatment of pneumonia and exacerbation of chronic bronchitis, Euroxime can be prescribed before oral administration of cefuroxime, when necessary.